AEterna Zentaris Inc.: Media Profile in Sources Directory 2008

1405, boul du Parc Technologique
Québec, QC G1P 4P5

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.
The company's two lead compounds, Centroelix and AEZS-108 have reached advanced and late-stage clinical development. Cetrorelix is in an ongoing Phase 3 program in benign prostatic hyperplasia (BPH) while AEZS-108 is in a Phase 2 trial for Endometrial and Ovarian cancer.
(TSX: AEZ; NASDAQ: AEZS)

World Wide Web: www.aezsinc.com

Paul Burroughs, Director of Communications
Phone: (418) 652-8525, ext. 406
FAX: (418) 948-9121
E-mail: pburroughs@aezsinc.com

Areas of Expertise:

Sources is a directory for journalists, writers, news editors, researchers. Use Sources to find experts, media contacts, spokespersons, scientists, lobbyists, officials, speakers, university professors, researchers, newsmakers, CEOs, executive directors, media relations contacts, spokespeople, talk show guests, PR representatives, Canadian sources, story ideas, research studies, databases, universities, colleges, associations, businesses, government, research institutions, lobby groups, non-government organizations (NGOs), in Canada and internationally.
© Sources 2008. The information provided is copyright and may not be reproduced in any form or by any means (whether electronic, mechanical or photographic), or stored in an electronic retrieval system, without written permission of the publisher. The content may not be resold, republished, or redistributed.